(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...
At Limitless Evolution, we focus on restoring function instead of masking symptoms. ReGen Medical RCT helps us support real healing with non-surgical, drug-free technology that works with the body.” — ...
Johnson & Johnson announced Friday it will buy medical device maker Shockwave Medical for nearly $13.1 billion in a move the company hopes will help it further combat heart disease. Founded in 1886, J ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results